Life Technologies Corp
DelistedCIK 1073431fmd_0GD7CES6CADXK6P3GS9GS9M6QXManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2008 to Sep 30, 2013, 20 periods
| Line item | FY2008 | FY2009 | FY2010 | FY2011 | FY2012 |
|---|---|---|---|---|---|
| Total revenues | 1,620 | 3,280 | 3,588 | 3,776 | 3,799 |
| Cost of revenue | 593 | 1,173 | 1,188 | 1,357 | 1,372 |
| Gross profit | 941 | 1,825 | 2,106 | 2,110 | 2,134 |
| Research and development | 143 | 337 | 375 | 378 | 342 |
| Selling, general and administrative | 499 | 987 | 1,023 | 1,009 | 1,055 |
| Total operating expenses | 774 | 1,439 | 1,494 | 1,462 | 1,469 |
| Operating income | 167 | 386 | 612 | 648 | 665 |
| Interest expense | 85 | 193 | 152 | 162 | 124 |
| Interest and investment income | 25 | 5 | 4 | 4 | 2 |
| Other non-operating income (expense) | (55) | (191) | (171) | (169) | (133) |
| Income before taxes | – | 195 | 442 | 479 | 532 |
| Income tax expense | 108 | 50 | 64 | 101 | 101 |
| Net income from continuing operations | 4 | 145 | 378 | 380 | 431 |
| Net income | 6 | 145 | 378 | 378 | 431 |
| Net income to common shareholders | 6 | 145 | 378 | 378 | 431 |